1. All of the plaintiffs' claims are dismissed.

2. The costs of lawsuit are assessed against the plaintiffs.

1. Basic facts

A. The deceased C (hereinafter referred to as “the deceased”) was under rehabilitation treatment in the Dazin Hospital, etc. as a person who was diagnosed by blood pressure around 1990, diagnosis by around 2005, diagnosis by cardiopulmonary Gyeong-dong around April 2014, tuberculosis diagnosis by around August 2014, and diagnosis by around 2015 due to acute cerebral cerebralopty, etc., and was under such rehabilitation treatment as the verbal disorder, flady disorder, the right flady disorder, and flady ma, etc., due to the tri-Seoul Hospital, etc., and the Plaintiffs are married of the deceased.

B. On February 2, 2016, the Deceased suffered symptoms, such as difficulty in respiratory, heat, and increase in the amount of carbon dioxide voltages in the process of being treated at the Suwon-Seoul Hospital (hereinafter “Defendant Hospital”), the Deceased was transferred to the Korea University Cancer Hospital operated by the Defendant (hereinafter “Defendant Hospital”).

C. The medical team of the Defendant Hospital conducted a chest CT test, a chest radiation test, a non-humane ray test, etc. on the deceased to a middle-patient, and conducted various medication medications, such as antibiotic virus infections, antibiotics, antibiotics, antibiotics, and artificial respiratorys treatment, etc. On the other hand, as a result of the cardiopulmonary wave test conducted against the deceased on February 3, 2016, symptoms such as cardiopulmonary dong, fluorum booms, malap, and cluorum fluor, etc. were confirmed.

As the deceased’s condition was improved, the medical team of the Defendant Hospital transferred the deceased from the middle patient’s room to the general sick room on March 1, 2016.

E. From March 4, 2016, the medical personnel of the Defendant Hospital expressed the number of 100cc and chere 100cc and chere (referring to the product name ke-pra, levetition agents of Lesathra (hereinafter referred to as “Kenya”) of the 500 ghume to the Deceased from March 4, 2016, and the quantity of drugs administered in the event of chere injection by means of chere injection is a unit indicating the quantity of drugs administered.

/ At a rate of 21:20 on the same day, the deceased’s guardian discontinued the amount of injection at a rate of 21:20 on the same day that the amount of injection is different from that of the patient, and at the time.